Viewing Study NCT02395692


Ignite Creation Date: 2025-12-24 @ 3:55 PM
Ignite Modification Date: 2026-02-21 @ 9:24 PM
Study NCT ID: NCT02395692
Status: TERMINATED
Last Update Posted: 2019-04-04
First Post: 2015-03-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2015-00356
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators